Proglumetacin
![]() Structure of proglumetacin | |||
Structures of the two metabolites | |||
Clinical data | |||
---|---|---|---|
Trade names | Afloxan, Protaxon, Proxil | ||
Other names | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate | ||
AHFS/Drugs.com | International Drug Names | ||
ATC code | |||
Pharmacokinetic data | |||
Metabolism | Hepatic. Undergoes enterohepatic recirculation | ||
Identifiers | |||
| |||
CAS Number | |||
PubChem CID | |||
ChemSpider | |||
UNII | |||
ChEBI | |||
CompTox Dashboard (EPA) | |||
Chemical and physical data | |||
Formula | C46H58ClN5O8 | ||
Molar mass | 844.45 g·mol−1 | ||
3D model (JSmol) | |||
| |||
| |||
(verify) |
Proglumetacin (usually supplied as the maleate salt) is a nonsteroidal anti-inflammatory drug (NSAID). It is a codrug (that is, a mutual prodrug) of indometacin and proglumide[1]. After oral intake, it is absorbed and metabolized to indometacin and proglumide. These two substances are then released into the system in a 1:1 molar ratio.
Indometacin contributes to the anti-inflammatory effect, while proglumide has antisecretory effects that helps prevent injury to the stomach lining.
References
[edit]